Vaxxas

0 followers


Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.

Industries

Headquarters

Stage

Employees

Links

Org chart

David Hoey

Collapse
Angus Forster
VP, Research & Development
Michael Junger
Head of Medical Device & Process Engineering
Charlotte Sweeney
Head of Formulation & Analytical
Damien Colbert
Head Of People And Performance
Deborah Pascoe, PhD
Head Of Early Stage And RNA Programs
Doug Cubbin
Chief Financial Officer
Paul Fahey
Head of Formulation & Analytical
Sarika Namjoshi, PhD
Head of Formulation and Analytical
Scott Fry
Chief Operating Officer
Dan Devine
Chief Business Officer/General Counsel/EVP
Kevin Black, CPA, MBA
Head, Special Projects
Michael Larcom
Senior Vice President of Quality